Insulin and insulin-like growth factor 1 stimulate proliferation of metastatic variants of colon carcinoma 26

Jpn J Cancer Res. 1989 Jan;80(1):51-8. doi: 10.1111/j.1349-7006.1989.tb02244.x.


The proliferation rate of malignant cells in vivo is one of the important factors which affect the formation of tumor metastasis. A highly metastatic variant of mouse colon adenocarcinoma 26 (NL-17) grew more rapidly than a low-metastatic variant (NL-44) both in vitro and in vivo. The effect of growth factors on the proliferation of NL-17 and NL-44 cells was examined in serum-free medium. Among growth factors examined, human insulin and insulin-like growth factor 1 (IGF-1), which were produced by gene engineering techniques, stimulated the growth of metastatic NL-17 and NL-44 cells as determined by thymidine incorporation and cell counts. DNA synthesis and cell proliferation of the high-metastatic NL-17 was stimulated to a greater extent by insulin and IGF-1 than those of the low-metastatic NL-44. These findings suggest that circulating growth factors could enhance the formation of tumor metastasis. Scatchard analysis of [125I]IGF-1 binding to NL-17 and NL-44 showed that each cell line had an almost equal number of IGF-1 receptors (1.37 x 10(5)/cell and 1.26 x 10(5)/cell, respectively), which had similar dissociation constants (8.94 x 10(-10) M and 9.54 x 10(-10) M, respectively). Since the number and affinity of IGF-1 receptors are equivalent between low- and high-metastatic cells, the intracellular events which result in the cell growth after binding of IGF-1 may differ between NL-17 and NL-44 cells.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adenocarcinoma / pathology*
  • Cell Division / drug effects
  • Colonic Neoplasms / pathology*
  • Growth Substances / pharmacology
  • Humans
  • Insulin / metabolism
  • Insulin / pharmacology*
  • Insulin-Like Growth Factor I / metabolism
  • Insulin-Like Growth Factor I / pharmacology*
  • Neoplasm Metastasis*
  • Receptors, Cell Surface / analysis
  • Receptors, Somatomedin
  • Somatomedins / pharmacology*
  • Tumor Cells, Cultured


  • Growth Substances
  • Insulin
  • Receptors, Cell Surface
  • Receptors, Somatomedin
  • Somatomedins
  • Insulin-Like Growth Factor I